Shareholders' Deficit (Details Textual) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 10 Months Ended | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 06, 2019 |
Jul. 31, 2019 |
Jul. 31, 2019 |
Jul. 31, 2019 |
Mar. 14, 2019 |
Mar. 12, 2019 |
Aug. 31, 2019 |
Jul. 31, 2019 |
Jul. 31, 2019 |
Jul. 29, 2019 |
May 20, 2019 |
Apr. 25, 2018 |
Sep. 30, 2019 |
Jun. 30, 2019 |
Mar. 31, 2019 |
Sep. 30, 2018 |
Jun. 30, 2018 |
Mar. 31, 2018 |
Sep. 30, 2019 |
Sep. 30, 2018 |
Dec. 27, 2016 |
Jul. 30, 2019 |
Jul. 28, 2019 |
Jul. 17, 2019 |
Jul. 12, 2019 |
Jan. 31, 2019 |
Dec. 31, 2018 |
Dec. 31, 2016 |
Dec. 31, 2015 |
|
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Stock-based compensation | $ 1,042,506 | $ 3,786,484 | |||||||||||||||||||||||||||
Issuance of common shares for services, amount | $ 47,000 | $ 114,460 | $ 10,000 | $ 20,000 | $ 68,750 | ||||||||||||||||||||||||
Stock-based professional fees | $ (292,785) | (80,417) | |||||||||||||||||||||||||||
Non-vested shares | |||||||||||||||||||||||||||||
Common share exercise compensation, shares | 750,000 | ||||||||||||||||||||||||||||
Common share exercise compensation periodic payment | $ 5,000 | ||||||||||||||||||||||||||||
Employee credited towards options exercise | 182,500 | $ 182,500 | $ 175,000 | ||||||||||||||||||||||||||
Option exercise price | $ 0.31 | ||||||||||||||||||||||||||||
Recognized compensation expense | $ 7,500 | 30,000 | |||||||||||||||||||||||||||
Weighted average period | 1 year | ||||||||||||||||||||||||||||
Subscription receivable | $ 19,185 | ||||||||||||||||||||||||||||
Aggregate principal amount | $ 25,000 | $ 25,000 | |||||||||||||||||||||||||||
Unrecognized compensation expense | 853,572 | ||||||||||||||||||||||||||||
Convert shares of common stock | 3.233733 | ||||||||||||||||||||||||||||
Convertible note [Member] | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Common shares issued for debt conversion, amount | $ 12,000 | ||||||||||||||||||||||||||||
Shares of common stock upon conversion | 295,567 | ||||||||||||||||||||||||||||
Former Chief Executive Officer [Member] | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Common shares per share | $ 0.05 | $ 0.04 | |||||||||||||||||||||||||||
Convert of deferred compensation | $ 40,000 | $ 80,000 | |||||||||||||||||||||||||||
Convert shares of common stock | 800,000 | 2,000,000 | |||||||||||||||||||||||||||
Chief Operating Officer[Member] | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Common shares per share | $ 0.05 | $ 0.04 | |||||||||||||||||||||||||||
Convert of deferred compensation | $ 80,000 | $ 50,000 | |||||||||||||||||||||||||||
Convert shares of common stock | 2,000,000 | 1,000,000 | |||||||||||||||||||||||||||
Fair market value of per share | $ 0.04 | $ 0.05 | |||||||||||||||||||||||||||
Long term incentive plan, description | These shares are issued under the Company’s 2018 Long-Term Incentive Plan and will vest on May 1, 2020. | These shares are issued under the Company’s 2018 Long-Term Incentive Plan and will vest on May 1, 2020. | |||||||||||||||||||||||||||
Two employees [Member] | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Common shares per share | $ 0.04 | ||||||||||||||||||||||||||||
Convert of deferred compensation | $ 24,000 | ||||||||||||||||||||||||||||
Convert shares of common stock | 600,000 | ||||||||||||||||||||||||||||
Long term incentive plan, description | These shares are issued under the Company’s 2018 Long-Term Incentive Plan and will vest on May 1, 2020. | ||||||||||||||||||||||||||||
2018 Long-term Incentive Plan [Member] | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Stock-based professional fees | $ 82,460 | ||||||||||||||||||||||||||||
2018 Long-term Incentive Plan [Member] | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Aggregate shares of common stock issued without any minimum vesting period | 25,000,000 | ||||||||||||||||||||||||||||
Aggregate number of common stock issued under plan | 50,000,000 | ||||||||||||||||||||||||||||
Incentive stock options | 11,445,698 | 11,445,698 | |||||||||||||||||||||||||||
Restricted stock have been issued | $ 13,950,000 | $ 13,950,000 | |||||||||||||||||||||||||||
2018 Long-term Incentive Plan [Member] | Employees [Member] | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Value of grant restricted stock award of common shares | 32,000 | ||||||||||||||||||||||||||||
Stock-based compensation | 17,333 | ||||||||||||||||||||||||||||
Prepaid expenses | 14,667 | $ 14,667 | |||||||||||||||||||||||||||
Vesting period | 1 year | ||||||||||||||||||||||||||||
Warrants [Member] | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Stock-based professional fees | $ 159,700 | $ 0 | |||||||||||||||||||||||||||
Warrant purchase, description | The Company, for $0.001 per each share of common stock covered, warrants to purchase an equal proportion of warrants to the number of shares issued or issuable to investors in the private placement. Additionally, per the terms of the Letter Agreement, upon signing of the agreement, the Company shall sell to Dinosaur, and Dinosaur shall purchase from the Company for $0.001 per each share of common stock covered, warrants (the "Warrants") to purchase 1,000,000 shares of C-Bond Common Stock, granted in three successive tranches as outlined below, with an exercise price of $0.18 or current market price at the time, whichever is lower, as set forth in the Letter Agreement. Upon signing of the Letter Agreement, Dinosaur received Warrants to purchase 200,000 shares of the Company's common stock at $0.18 per share. On June 14, 2019, the three-month anniversary of the Letter Agreement, Dinosaur received Warrants to purchase 400,000 shares of the Company's common stock at $0.08 per share. On the six-month anniversary of the Letter Agreement, Dinosaur received Warrants to purchase 400,000 shares of the Company's common stock at $0.05 per share. The Warrants shall be exercisable over a five-year term from date each tranche date and shall be assignable to others at Dinosaur's discretion. In the event either party terminates the Letter agreement before the three or six month anniversary, the Company has no obligation to sell the common stock or related Warrants referenced herein. These warrants were valued at the grant date using a Black-Scholes option pricing model with the following assumptions; risk-free interest rate of 2.43%, expected dividend yield of 0%, expected warrant term of five years, and an expected volatility of 275.0%. The aggregate grant date fair value of these awards amounted to $159,700. The Company recognizes compensation cost for unvested stock-based warrant awards on a straight-line basis over the requisite service period. For the nine months ended September 30, 2019 and 2018, the Company recorded $159,700 and $0 of stock-based professional fees related to stock warrants, respectively. | ||||||||||||||||||||||||||||
Total unrecognized professional fee expense related to unvested stock warrants | 26,243 | $ 26,243 | |||||||||||||||||||||||||||
Risk-free rate | 2.43% | ||||||||||||||||||||||||||||
Dividend yield | 0.00% | ||||||||||||||||||||||||||||
Expected term | 5 years | ||||||||||||||||||||||||||||
Expected volatility | 275.00% | ||||||||||||||||||||||||||||
Fair value of the award amount | $ 159,700 | ||||||||||||||||||||||||||||
Subscription Agreement One [Member] | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Advanced proceeds from investor | $ 330,000 | ||||||||||||||||||||||||||||
Purchase of shares | 7,750,000 | ||||||||||||||||||||||||||||
Subscription Agreement [Member] | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Common shares per share | $ 0.85 | $ 0.77 | |||||||||||||||||||||||||||
Advanced proceeds from investor | $ 300,000 | ||||||||||||||||||||||||||||
Purchase of shares | 2,000,000 | ||||||||||||||||||||||||||||
Consulting agreement [Member] | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Issuance of common shares for services, shares | 485,060 | ||||||||||||||||||||||||||||
Issuance of common shares for services, amount | $ 82,460 | ||||||||||||||||||||||||||||
Securities purchase agreement | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Warrant purchase, description | The Company issued a warrant to purchase up to 750,000 shares of the Company’s common stock (the “Warrant”). The Warrant is exercisable at any time on or after the date of the issuance and entitles this investor to purchase shares of the Company’s common stock for a period of five years from the initial date the warrants become exercisable. Under the terms of the Warrant, the holder is entitled to exercise the Warrant to purchase up to 750,000 shares of the Company’s common stock at an initial exercise price of $0.10, subject to adjustment as detailed in the Warrant. In connection with the issuance of the warrants, on the initial measurement date, the relative fair value of the warrants of $44,530 was recorded as a debt discount and an increase in paid-in capital (See Note 6). | ||||||||||||||||||||||||||||
Restricted common shares [Member] | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Common shares per share | $ 0.05 | ||||||||||||||||||||||||||||
Shares of grant restricted stock award of common shares | 10,500,000 | ||||||||||||||||||||||||||||
Value of grant restricted stock award of common shares | $ 525,000 | ||||||||||||||||||||||||||||
Restricted stock award agreements, description | These shares will vest on May 1, 2020. If the employee’s employment is terminated for any reason, these shares will immediately be forfeited. In the event of a change of control, the employee shall be 100% vested in all shares of restricted shares subject to these Agreements. | ||||||||||||||||||||||||||||
Restricted common shares [Member] | Employees [Member] | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Issuance of common shares for services, shares | 200,000 | ||||||||||||||||||||||||||||
Non-vested shares | 1,845,834 | 973,957 | |||||||||||||||||||||||||||
Total unrecognized compensation expense related to unvested common shares | $ 431,248 | $ 431,248 | |||||||||||||||||||||||||||
Restricted common shares [Member] | Consulting agreement [Member] | Employees [Member] | |||||||||||||||||||||||||||||
Shareholders' Deficit (Textual) | |||||||||||||||||||||||||||||
Shares of grant restricted stock award of common shares | 500,000 | ||||||||||||||||||||||||||||
Value of grant restricted stock award of common shares | $ 47,000 | ||||||||||||||||||||||||||||
Stock-based compensation | 33,292 | ||||||||||||||||||||||||||||
Prepaid expenses | $ 13,708 |